4 Intermolecular Analyst Ratings, Earnings, Dividends and Insider Trades | $IMI | NASDAQ:IMI | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Intermolecular Company Profile (NASDAQ:IMI) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Intermolecular (NASDAQ:IMI) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s)Consensus Rating:Hold (Score: 1.50)Consensus Price Target: $9.00 (232.10% upside) Analysts' Ratings History for Intermolecular (NASDAQ:IMI) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/7/2014JPMorgan Chase & Co.Lower Price Target$12.00 -> $9.00View 1/6/2014Needham & CompanyDowngradeBuy -> HoldView 7/26/2013Needham & CompanyLower Price TargetBuy$12.00 -> $10.00View 7/10/2013JPMorgan Chase & Co.DowngradeNeutralView 7/10/2013JPMorgan Chase & Co.DowngradeOverweight -> Neutral$15.00 -> $12.00View 5/28/2013TheStreetDowngradeHold -> SellView 4/18/2013Needham & CompanyBoost Price Target$11.00 -> $12.00View 1/18/2013Needham & CompanyBoost Price TargetBuy$10.00 -> $11.00View 6/25/2012Morgan StanleyInitiated CoverageEqualweightView 4/27/2012JPMorgan Chase & Co.Lower Price TargetOverweight$17.00 -> $12.00View 4/27/2012Needham & CompanyReiterated RatingBuyView 4/27/2012Needham & CompanyBoost Price TargetHold$10.00 -> $13.00View (Data available from 3/11/2012 forward) Earnings History for Intermolecular (NASDAQ:IMI)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView 2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView 2/6/2014Q413($0.07)($0.07)$15.57 million$15.60 millionViewN/AView 10/24/2013Q313($0.03)($0.05)$15.50 million$17.70 millionViewN/AView 7/25/2013Q213($0.01)$0.01$16.54 million$16.60 millionViewN/AView 4/25/2013Q1 2013$0.00$0.03$16.97 million$17.43 millionViewN/AView 2/7/2013Q4 2013$0.01$0.03$16.68 million$17.40 millionViewN/AView 10/25/2012($0.03)$0.02ViewN/AView 7/26/2012($0.03)($0.02)ViewN/AView 4/26/2012($0.01)$0.00ViewN/AView 2/7/2012($0.04)$0.00ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Intermolecular (NASDAQ:IMI)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Intermolecular (NASDAQ:IMI)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare3/3/2014Tony ChiangCTOSell1,476$2.64$3,896.64View 2/6/2014David LazovskyCEOSell4,552$4.02$18,299.04View 1/28/2014Sandeep JaggiSVPSell2,322$4.06$9,427.32View 1/28/2014Sandeep NijhawanVPSell4,064$4.06$16,499.84View 1/28/2014Tony ChiangCTOSell1,742$4.06$7,072.52View 12/10/2013David LazovskyCEOSell38,500$5.33$205,205.00View 12/4/2013Tony ChiangCTOSell30,000$5.52$165,600.00View 11/8/2013David LazovskyCEOSell38,500$5.58$214,830.00View 10/8/2013David LazovskyCEOSell38,500$5.80$223,300.00View 9/9/2013David E LazovskyCEOSell38,500$5.89$226,765.00View 9/5/2013Tony ChiangCTOSell39,003$5.97$232,847.91View 8/7/2013David LazovskyCEOSell38,500$6.20$238,700.00View 8/1/2013Tony P ChiangCTOSell48,000$6.31$302,880.00View 7/16/2013Peter L EidelmanCFOSell21,753$6.96$151,400.88View 7/8/2013David E LazovskyCEOSell38,500$7.34$282,590.00View 7/3/2013Tony P ChiangCTOSell78,000$7.23$563,940.00View 6/17/2013Peter L EidelmanCFOSell6,500$7.30$47,450.00View 6/7/2013David E LazovskyCEOSell38,500$8.22$316,470.00View 6/3/2013James Craig HunterSVPSell3,500$8.43$29,505.00View 5/23/2013Tony P ChiangCTOSell52,926$8.40$444,578.40View 5/16/2013Peter L EidelmanCFOSell6,500$8.68$56,420.00View 3/25/2013Tony P ChiangCTOSell25,000$9.53$238,250.00View 2/26/2013Tony P ChiangCTOSell72,612$9.55$693,444.60View 2/21/2013Bruce M McwilliamsDirectorSell2,132$9.64$20,552.48View 1/17/2013Bruce M McwilliamsDirectorSell21,200$9.27$196,524.00View 12/3/2012John R BehnkeSVPSell2,500$6.99$17,475.00View 10/8/2012David E LazovskyCEOSell26,810$7.23$193,836.30View 9/5/2012James Craig HunterSVPSell3,500$7.20$25,200.00View 8/23/2012Tony P ChiangCTOSell14,266$7.15$102,001.90View (Data available from 1/1/2013 forward) About Intermolecular Intermolecular, Inc. (Intermolecular) is engaged in research and development and time-to-market for the semiconductor and clean-energy industries. The Company, through paid collaborative development programs (CDPs) with its customers, develops technology and intellectual property (IP) for its customers focused on advanced materials, processes, integration and device architectures. The Company provides its customers with technology through various fee arrangements and grants them rights to associated IP, primarily through royalty-bearing licenses. Through paid CDPs and its own development, the Company has established a portfolio of greater than 1,000 patents and patent applications. Its approach is broadly applicable to high-volume integrated device markets, which include the markets for semiconductors, flat glass coatings and glass-based devices, solar cells, light-emitting diodes (LEDs), flat-panel displays, advanced batteries and other energy efficiency applications. Headlines: (2/27) Intermolecular Announces New Developments in the SanDisk/Toshiba Relationship (2/11) Intermolecular(R) and Guardian Industries Expand Collaboration and Strategic IP Licensing Agreement (2/28) Why Intermolecular (IMI) Is Down Today (2/10) Weakness Seen in Intermolecular (IMI): Stock Tumbles 8.5% Industry, Sector and Symbol: Sector: Information Technology Industry: Semiconductors & Semiconductor Equipment Sub-Industry: Semiconductors Exchange: NASDAQ Symbol: IMI CUSIP: 45882D10 Key Metrics: Previous Close: $2.7850 Day Moving Average: $3.7271200 Day Moving Average: $5.0985 P/E Ratio: N/AP/E Growth: N/AMarket Cap: $124.3MCurrent Quarter EPS Consensus Estimate: $-0.12 EPS Additional Links: View IMI on Google FinanceView IMI on Yahoo FinanceView IMI's Company Profile on ReutersSearch for Intermolecular Inc. on Google Intermolecular (NASDAQ:IMI) Chart for Tuesday, March, 11, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.